Bleeding Edge

The Bleeding Edge is the only free newsletter that features investing insights from editor Colin Tedards. Here, Colin will share what he's watching in the market and which stocks you'll want on your radar.


The Beginning of the End for Big Pharma

Billionaire Mark Cuban’s company, Cost Plus Drugs, has just teamed up with grocery retailer giant Kroger to disrupt the entire pharmaceutical industry. And it has major implications for us as consumers… and investors. Could this be the beginning of the end for Big Pharma?


The “Spooky” Side of AI

In this mailbag edition, readers inquire about the GPU hardware market amid shortages… and how Disney’s share price could be affected by its troubles with ESPN… Colin also explores more of the “spooky” implications of AI.

Meet RT-2

Google DeepMind's latest AI-powered robot is a breakthrough in interactive robotics. And it's paving the way for more advanced robots to be programmed in the future...